| InflaRx N.V.. (12/21/22). "Press Release: InflaRx Announces Amendment of Co-Development Agreement and Additional Equity Investment by Staidson in Connection with Regulatory Filing in China for Anti-C5a-Antibody for Treatment of COVID-19". Jena. |
2022-12-21 |
| European Invesmtent Bank (EIB). (12/20/22). "Press Release: Germany – EIB Provides €20 Million in Financing to Innovative Diagnostics Developer Numares". |
2022-12-20 |
| MorphoSys AG. (12/20/22). "Press Release: Chief Financial Officer Sung Lee to Leave MorphoSys in March 2023". Planegg. |
2022-12-20 |
| Boehringer Ingelheim. (12/20/22). "Press Release: Boehringer Ingelheim Announces Appointments to Board of Managing Directors". Ingelheim. |
2022-12-20 |
| Nykode Therapeutics A/S. (12/19/22). "Press Release: Nykode Therapeutics and Richter-Helm BioLogics Announce Strategic Manufacturing Partnership". Oslo. |
2022-12-19 |
| CN Bio Innovations Ltd.. (12/19/22). "Press Release: CN Bio Appoints Dr Paul Brooks as Chief Executive Officer". Cambridge. |
2022-12-19 |
| Eckert & Ziegler Strahlen- und Medizintechnik AG. (12/19/22). "Press Release: Changes in the Management Board of Eckert & Ziegler. Insider Information Pursuant to Article 17 MAR". Cambridge. |
2022-12-19 |
| ADC Therapeutics S.A.. (12/19/22). "Press Release: ADC Therapeutics Appoints Jose Carmona as Chief Financial Officer". Lausanne. |
2022-12-19 |
| CRISPR Therapeutics AG. (12/19/22). "Press Release: CRISPR Therapeutics Announces the Appointment of Alex Harding, M.D., M.B.A., as Head of Business Development". Zug & Boston, MA. |
2022-12-19 |
| Boehringer Ingelheim. (12/19/22). "Press Release: Boehringer Ingelheim and Click Therapeutics Expand Their Existing Collaboration to Develop Prescription Digital Therapeutics for Schizophrenia". Ingelheim & New York, NY. |
2022-12-19 |
| Polyplus-transfection S.A.. (12/17/22). "Press Release: Polyplus Acquires Xpress Biologics to Expand Plasmid DNA Offer". Strasbourg. |
2022-12-17 |
| BioSpring GmbH. (12/16/22). "Press Release: BioSpring Expands in Offenbach – up to 1,500 New Jobs". Offenbach am Main. |
2022-12-16 |
| Beiersdorf AG. (12/16/22). "Press Release: Beiersdorf Acquires S-Biomedic and Strengthens Expertise in the Field of Acne Treatment". Hamburg. |
2022-12-16 |
| Minervax ApS. (12/15/22). "Press Release: Minervax Announces 72M EUR Financing to Advance Development of Novel Vaccine against Group B Streptococcus". Copenhagen. |
2022-12-15 |
| T-Curx GmbH. (12/15/22). "Press Release: T-Curx GmbH Announces the Appointment of Thomas (Tom) Loeser as CFO and the Attendance at the JPM 41st Annual Healthcare Conference 2023 in San Francisco". Würzburg. |
2022-12-15 |
| Storm Therapeutics Ltd.. (12/14/22). "Press Release: Storm Therapeutics Announces Closing of USD $30M Series B Financing". Cambridge. |
2022-12-14 |
| Merck KGaA. (12/13/22). "Press Release: Merck Signs MoU with Synplogen to Accelerate Development and Manufacturing of Viral Vector-based Gene Therapy Applications". Tokyo. |
2022-12-13 |
| Lipotype GmbH. (12/13/22). "Press Release: Lipotype, a Leading Lipidomics Service Provider, Launches US Subsidiary in Cambridge, Massachusetts". Cambridge, MA & Dresden. |
2022-12-13 |
| Amgen Inc.. (12/13/22). "Press Release: Blincyto (blinatumomab) Added to Consolidation Chemotherapy Significantly Improves Survival in Adult Patients with Measurable Residual Disease-negative B-Lieage Acute Lymphoblastic Leukemia (B-ALL)". Thousand Oaks, |
2022-12-13 |
| Genedata AG. (12/12/22). "Press Release: Icosagen Chooses Genedata Biologics to Digitalize Recombinant Antibody Discovery". Basel. |
2022-12-12 |
| TGZ Halle Technologie- und Gründerzentrum Halle GmbH. (12/12/22). "Pressemitteilung: Minister Schulze übergibt Fördermittelbescheide für Neubauten". |
2022-12-12 |
| BioM Biotech Cluster Development GmbH. (12/12/22). "Press Release: Martinsried Gets Start-up Incubator Munich Accelerator Life Sciences & Medicine (MAxL)". Martinsried. |
2022-12-12 |
| Stadt Köln. (12/9/22). "Pressemitteilung: Rat gibt Mittel für Planung von Neubauten auf dem BioCampus Cologne frei". |
2022-12-09 |
| Ryvu Therapeutics S.A.. (12/8/22). "Press Release: Ryvu Therapeutics Initiates Public Offering of Shares [not for US, AU, CA, et al.]". Krakow. |
2022-12-08 |
| Sartorius AG. (12/8/22). "Press Release: Sartorius Agrees with Bico on Strategic Cooperation as well as a 10 Percent Capital Investment". Göttingen. |
2022-12-08 |
| Max Planck Institute of Biochemsitry. (12/8/22). "Press Release: Karsten Borgwardt Becomes Director at the Max Planck Institute of Biochemistry". Martinsried. |
2022-12-08 |
| High-Tech Gründerfonds Management GmbH. (12/7/22). "Press Release: Variolytics Receives Seven-figure Seed Funding for Climate-neutral Wastewater Treatment Plants". Stuttgart. |
2022-12-07 |
| Merck KGaA. (12/6/22). "Press Release: Merck Gains Leading Perfusion Micro-Bioreactor with Erbi Biosystems Acquisition". Darmstadt. |
2022-12-06 |
| MorphoSys AG. (12/6/22). "Press Release: MorphoSys Out Licenses Pre-Clinical Oncology Program". Planegg. |
2022-12-06 |
| Bruker Corporation. (12/5/22). "Press Release: Bruker Completes the Acquisition of Neurescence Inc.". Billerica, MA. |
2022-12-05 |
| Fresenius Medical Care AG & Co. KGaA. (12/5/22). "Press Release: Helen Giza to Take Over as Chief Executive Officer of Fresenius Medical Care". |
2022-12-05 |
| faCelliate GmbH. (11/30/22). "Press Release: faCellitate Appoints Christoph Petry, Ph.D. to Become Managing Director and CEO". Mannheim. |
2022-11-30 |
| BioNTech SE. (11/30/22). "Press Release: BioNTech and Ryvu Therapeutics Enter into Global Collaboration to Develop and Commercialize Immuno-Modulatory Small Molecule Candidates". Mainz & Krakow. |
2022-11-30 |
| Cajal Neuroscience. (11/29/22). "Press Release: Cajal Neuroscience Launches with $96 Million to Transform Target and Drug Discovery in Neurodegeneration". Seattle, WA. |
2022-11-29 |
| Rgenta Therapeutics, Inc.. (11/29/22). "Press Release: Rgenta Therapeutics Raises $52M in Series A Financing". Cambridge, MA. |
2022-11-29 |
| MiGenTra GmbH. (11/29/22). "Press Release: Bioventure, Minapharm Pharmaceuticals and MiGenTra Sign an Exclusive Agreement for the Commercialization of Multiple Biosimilar Candidates of Alvotech in the Middle East and Africa". |
2022-11-29 |
| Technische Universität München. (11/28/22). "Press Release: Nanoswitches for Tumor Targeting. TUM Spin-off Plectonic Develops Antibody-based Immunotherapies". |
2022-11-28 |
| Temedica GmbH. (11/23/22). "Press Release: Temedica Raises another €25 Million in Series B Funding to Expand Its Unique Real-world Insights Ecosystem". Munich. |
2022-11-23 |
| ObsEva S.A.. (11/22/22). "Press Release: ObsEva Announces Sale of Ebopiprant License Agreement to XOMA for up to $113 Million". Geneva. |
2022-11-22 |
| Turbine Simulated Cell Technologies Ltd.. (11/22/22). "Press Release: Turbine Raises €20 Million in Series A Financing to Advance Programs & Partnerships Towards the Clinic with World’s First Cancer Cell Simulation Platform". London & Budapest. |
2022-11-22 |
| Oxford Biomedica plc. (11/22/22). "Press Release: Oxford Biomedica Appoints Dr Frank Mathias as Chief Executive Officer". Oxford. |
2022-11-22 |
| Catalym GmbH. (11/22/22). "Press Release: Catalym Closes EUR 50 Million Series C Financing to Expand and Accelerate Phase 2 Clinical Development of Visugromab in Patients with Solid Tumors". Oxford. |
2022-11-22 |
| FogPharma (Fog Pharmaceuticals Inc.). (11/21/22). "Press Release: FogPharma Announces $178 Million Series D Financing to Advance Pipeline of First-in-Class Helicon Polypeptide Therapeutics Targeting Major Cancer Drivers". Cambridge, MA. |
2022-11-21 |
| Xlife Sciences AG. (11/21/22). "Press Release: Xlife Sciences Initiates a Review of Strategic Options". Zürich. |
2022-11-21 |
| European Invesmtent Bank (EIB). (11/18/22). "Press Release: Marjut Falkstedt Appointed as Chief Executive of the European Investment Fund". |
2022-11-18 |
| Cradle Bio B.V.. (11/17/22). "Press Release: Biotech Startup Cradle Exits Stealth, Raises $5.5M to Design Protein-machines and Cell-factories with AI". |
2022-11-17 |
| Valneva S.E.. (11/17/22). "Press Release: Valneva Appoints Dipal Patel as Chief Commercial Officer". Saint-Herblain. |
2022-11-17 |
| Sarcura GmbH. (11/17/22). "Press Release: Sarcura Secures € 7M Seed Plus Funding to Revolutionize Cell Therapy Manufacturing". Klosterneuburg. |
2022-11-17 |
| High-Tech Gründerfonds Management GmbH. (11/17/22). "Press Release: FundaMental Pharma Launches with EUR 10 Million in Seed Financing Led by BGV and Thuja Capital to Advance a First-in-Class Neuroprotectant". Heidelberg. |
2022-11-17 |
| Merck KGaA. (11/21622). "Press Release: Merck Invests € 290 Million in U.S. Drug Safety Testing Capacity". Darmstadt. |
2022-11-16 |
| Rentschler Biopharma SE. (11/16/22). "Press Release: Rentschler Biopharma Appoints Christiane Bardroff as Chief Operating Officer and Member of the Executive Board". Laupheim. |
2022-11-16 |
| Novigenix S.A.. (11/16/22). "Press Release: Novigenix Announces First Closing of Its $20M Series B". Lausanne. |
2022-11-16 |
| Jnana Therapeutics Inc.. (11/15/22). "Press Release: Jnana Therapeutics Announces Second Collaboration with Roche to Address Challenging-to-Drug Targets in Cancer, Immune-Mediated and Neurological Diseases". Boston, MA. |
2022-11-15 |
| Jnana Therapeutics Inc.. (11/15/22). "Press Release: Jnana Therapeutics Raises $107 Million to Advance Lead PKU Program and Progress Therapeutics Pipeline Discovered by the RAPID Platform". Boston, MA. |
2022-11-15 |
| MorphoSys AG. (11/14/22). "Press Release: MorphoSys’ Licensing Partner Roche Provides Update on Phase 3 GRADUATE Program for Gantenerumab in Early Alzheimer’s Disease". Planegg. |
2022-11-14 |
| BioNTech SE. (11/14/22). "Press Release: BioNTech Expands Global Footprint by Acquiring GMP Manufacturing Site to Establish First mRNA Facility in Singapore". Mainz & Singapore. |
2022-11-14 |
| Roche. (11/14/22). "Press Release: Roche Provides Update on Phase III GRADUATE Programme Evaluating Gantenerumab in Early Alzheimer’s Disease". Basel. |
2022-11-14 |
| Bruker Corporation. (11/14/22). "Press Release: Bruker Announces Agreement to Acquire Neurescence Inc., Bolstering Neuroscience Research Portfolio". Billerica, MA. |
2022-11-14 |
| Air Liquide Healthcare. (11/14/22). "Press Release: Air Liquide Healthcare Federates Its Biobanking Activity under the Name BioKryo and Inaugurates Its New Site in Germany". Bagneux. |
2022-11-14 |
| Sartorius AG. (11/11/22). "Press Release: Sartorius Successfully Places Schuldschein Loans with a Volume of 650 Million Euros". Göttingen. |
2022-11-11 |
| Seagen Inc.. (11/10/22). "Press Release: Seagen Names David R. Epstein as Chief Executive Officer and Director". Bothell, WA. |
2022-11-10 |
| Bayer AG. (11/10/22). "Press Release: Bayer Acquires German Biotech Start-up Targenomix". Monheim. |
2022-11-10 |
| Atriva Therapeutics GmbH. (11/9/22). "Press Release: Atriva Therapeutics Appoints Christian Pangratz as Chief Executive Officer, Implementing Planned Management Change". Tübingen, Frankfurt a.M. & Martinsried. |
2022-11-09 |
| Bruker Corporation. (11/8/22). "Press Release: Bruker Announces Acquisition of Inscopix for Neuroscience Research". Mountain View, CA. |
2022-11-08 |
| BioGeneration Ventures B.V.. (11/8/22). "Press Release: BGV Appoints Elena Ritsou as Venture Partner and Andree Blaukat as Senior Advisor". Amsterdam. |
2022-11-08 |
| BC Platforms AG. (11/8/22). "Press Release: BC Platforms Announces USD 20 Million Growth Financing Led by Jolt Capital". |
2022-11-08 |
| Merck KGaA. (11/7/22). "Press Release: Merck Announces Collaboration with Biotheus to Accelerate Drug Submission and Approval Process for Biopharmaceutical Industry in China". Shanghai. |
2022-11-07 |
| Bruker Corporation. (11/7/22). "Press Release: Bruker Corporation to Participate in the 2022 Jefferies London Healthcare Conference". Billerica, MA. |
2022-11-07 |
| Exscientia plc. (11/3/22). "Press Release: Exscientia Expands Biologics Design Capability with Automated Laboratory". Oxford. |
2022-11-03 |
| Affimed N.V.. (11/3/22). "Press Release: Affimed and Artiva Biotherapeutics Announce Partnership to Advance Combination Therapy of Innate Cell Engager (ICE) AFM13 and Off-the-Shelf Allogeneic NK Cell Therapy AB-101". Heidelberg & San Diego, CA. |
2022-11-03 |
| Centogene N.V.. (11/3/22). "Press Release: Centogene Launches Rare and Neurodegenerative Disease Biodata Network". Cambridge, MA, Rostock & Berlin. |
2022-11-03 |
| Bayer AG. (11/3/22). "Press Release: Leaps by Bayer Leads Investment Round in AgTech Pioneer NuCicer to Bring Unique and Cost-effective Plant-protein Ingredients to Market by 2023". Davis, CA & Leverkusen. |
2022-11-03 |
| Alterome Therapeutics, Inc.. (11/2/22). "Press Release: Alterome Therapeutics Extends Series A to Nearly $100 Million to Advance Alteration-Specific Cancer Therapies". San Diego, CA. |
2022-11-02 |
| ADC Therapeutics S.A.. (11/1/22). "Press Release: ADC Therapeutics Appoints Kristen Harrington-Smith as Chief Commercial Officer and Peter Graham as Chief Legal Officer". Lausanne. |
2022-11-01 |
| Memo Therapeutics AG. (11/1/22). "Press Release: Memo Therapeutics AG and Ono Pharmaceutical Enter Antibody Discovery Partnership for Immuno-oncology Targets". Schlieren. |
2022-11-01 |
| Affimed N.V.. (11/1/22). "Press Release: Affimed to Present at the 2022 Jefferies London Healthcare Conference". Heidelberg. |
2022-11-01 |
| ASC Oncology GmbH. (11/1/22). "Press Release: ASC Oncology Proudly Announces New Partnership with Tamer Group". Berlin. |
2022-11-01 |
| Evotec SE. (10/28/22). "Press Release: Evotec, CDP Venture Capital and Angelini Ventures Launch Translational Partnership »Extend« with Leading Italian Academic Institutions". Hamburg. |
2022-10-28 |
| Ariceum Therapeutics GmbH. (10/27/22). "Press Release: Ariceum Therapeutics and AmbioPharm Enter Strategic Manufacturing and Supply Partnership". Berlin & North Augusta, SC. |
2022-10-27 |
| MorphoSys AG. (10/27/22). "Press Release: GSK, MorphoSys’ Licensing Partner, Provides Update on ContRAst Phase III Program for Otilimab in Moderate to Severe Rheumatoid Arthritis". Planegg. |
2022-10-27 |
| Kizoo Technology Capital GmbH. (10/26/22). "Press Release: Kizoo Invests in Rejuvenation Startup MoglingBio". Berlin & Ulm. |
2022-10-26 |
| ObsEva S.A.. (10/26/22). "Press Release: ObsEva Announces Progress on Cost Reduction Initiatives and Stay of Moratorium Proceedings". Geneva. |
2022-10-26 |
| Medicines Discovery Catapult (MDC). (10/26/22). "Press Release: Medicines Discovery Catapult Appoints International Entrepreneur Volker Hirsch to Bolster Commercial Expertise". |
2022-10-26 |
| Evotec SE. (10/25/22). "Press Release: Evotec Enters Partnership with Hannover Medical School to Create Molecular Patient Database in Autoimmune Diseases". Hamburg. |
2022-10-25 |
| Resolve Biosciences GmbH. (10/25/22). "Press Release: Resolve Biosciences Appoints Chief Commercial Officer to Drive Worldwide Adoption of Molecular Cartography Workflow". Monheim. |
2022-10-25 |
| Alto Neuroscience Inc.. (10/25/22). "Press Release: Alto Neuroscience Announces $35 Million Series B Financing". Los Altos, CA. |
2022-10-25 |
| Proteros Biostructures GmbH. (10/25/22). "Press Release: Proteros and Adrestia Initiate Multi-target Partnership to Discover First-in-class Drugs for Intractable Genetic Diseases". Martinsried. |
2022-10-25 |
| Resolve Biosciences GmbH. (10/24/22). "Press Release: Resolve Biosciences Secures $71 Million Series B Financing to Accelerate Commercial Expansion to Meet Global Demand for Molecular Cartography Workflow". Monheim. |
2022-10-24 |
| Boehringer Ingelheim. (10/20/22). "Press Release: University of Tübingen and Boehringer Ingelheim Join Forces to Lead AI and Data Science R&D for New Medical Breakthroughs". Tübingen & Ingelheim. |
2022-10-20 |
| Hookipa Pharma Inc.. (10/20/22). "Press Release: Hookipa Announces Strategic Collaboration and License Agreement with Roche to Develop Novel Arenaviral Immunotherapy for KRAS-mutated Cancers". New York, NY & Vienna. |
2022-10-20 |
| FyoniBio GmbH. (10/20/22). "Press Release: FyoniBio and Strike Pharma Sign a Master Service Agreement Covering Cell Line Development for a Novel Bi-specific Therapeutic mAb". Berlin & Stockholm. |
2022-10-20 |
| HMNC Holding GmbH. (10/20/22). "Press Release: HMNC Brain Health Raises EUR 14.3 million to Advance Precision Psychiatry Therapies". Munich. |
2022-10-20 |
| Nucleome Therapeutics Ltd.. (10/19/22). "Press Release: Nucleome Therapeutics Raises oversubscribed £37.5 Million Series A Financing to Decode the Dark Matter of the Human Genome and Deliver First-in-Class Precision Medicines". Oxford. |
2022-10-19 |
| Celeris Therapeutics GmbH. (10/19/22). "Press Release: Celeris Therapeutics to Receive 12.5 Million Euros in Funding from the European Innovation Council". Graz. |
2022-10-19 |
| Empyrean Neuroscience, Inc.. (10/18/22). "Press Release: Empyrean Neuroscience Launches with $22M Series A and Genetic Engineering Platform to Advance Pipeline of Neuroactive Compounds Targeting CNS Disorders". New York, NY & Cambridge. |
2022-10-18 |
| Anokion S.A.. (10/18/22). "Press Release: Anokion Announces $35 Million Equity Investment from Pfizer". Cambridge, MA & Lausanne. |
2022-10-18 |
| Co.don AG. (10/17/22). "Pressemitteilung: Vereinbarung über die Veräußerung des Geschäftsbetriebs". Teltow & Leipzig. |
2022-10-17 |
| BioM Biotech Cluster Development GmbH. (10/12/22). "Press Release: Osaka and Munich Continue Their Cuccessful Partnership". |
2022-10-12 |
| Wacker Chemie AG. (10/12/22). "Press Release: Neuway Pharma and Wacker Launch Research Project to Develop RNA-Based Actives for the Treatment of Central Nervous System Diseases". Munich & Bonn. |
2022-10-12 |
| faCelliate GmbH. (10/11/22). "Press Release: faCellitate Starts Marketing New 384-well Spheroid Microplate". Mannheim. |
2022-10-11 |
![[LSG] Life-Sciences-Germany.com - The Life Sciences Web Portal for German-speaking Europe](/images/basics/lsg-life-sciences-germany-portal-logo.svg){kind=logo}
1 2 3 ... 5 6 7 ... 53 54 55 
Date
![Picture [iito] LSE iitoLifeScience Life Sciences Mass Spec 120x120px](/banner/iito-business-intelligence-20230710-120-120-twitter-iitolifescience-germany-europe-mass-spec.jpg)
![Picture [LSE] Life-Sciences-Europe.com – The Business Web Portal 120x600px](/banner/iito-20150801-120-600-lse-life-sciences-europe-com.jpg)
![Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 120x600px](/banner/iito-20181119-120-600-lsus-life-sciences-usa-com.jpg)
